BioGend (6733.TWO) monthly revenue, September 2026
BioGend reported revenue of NT$0.02bn for September 2026, up 10.9% from the previous month and up 9.5% from a year earlier. Year-to-date revenue was NT$0.17bn, up 8.0% year on year. It ranked 80 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.02 | 10.9 | 9.5 |